ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2805 • 2019 ACR/ARP Annual Meeting

    Natural Killer Cells Gene Expression Can Differentiate Rheumatoid Arthritis Patients from Healthy Controls

    Noha Elemam1, Mahmood Hachim 1, Suad Hannawi 2 and Azzam Maghazachi 1, 1Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, Sharjah, United Arab Emirates, 2Ministry of Health and Prevention-UAE, Department of Rheumatology, Dubai, United Arab Emirates

    Background/Purpose: Rheumatoid arthritis (RA) is the most prevalent autoimmune diseases (1-3% of the world’s population). RA is a prototypic inflammatory disease, being characterized by an…
  • Abstract Number: 2806 • 2019 ACR/ARP Annual Meeting

    Single Cell RNA-sequencing Reveals Distinct Macrophage Subsets in the Joint with Differing Ontogenies During Steady-state and Arthritis

    Anna Montgomery 1, Shang-Yang Chen1, Philip Homan 1, Gaurav Gadhvi 1, Deborah Winter 2 and Harris Perlman 2, 1Northwestern University, Chicago, 2Northwestern University Feinberg School of Medicine, Division of Rheumatology, Chicago

    Background/Purpose: Macrophages in the synovial lining of the joint are critical players in the pathogenesis of rheumatoid arthritis (RA). However, their heterogeneity remains poorly characterized.Methods:…
  • Abstract Number: 2807 • 2019 ACR/ARP Annual Meeting

    Activation of the STING Pathway Is a Shared Feature of Salivary Gland and Lung Inflammation in Sjogren’s Syndrome

    Joanna Papinska 1, Grzegorz Gmyrek 2, Umesh Deshmukh1 and Harini Bagavant 1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Oklahoma Medical Research Foundation, Oklahoma City

    Background/Purpose: Sjögren’s syndrome is a chronic autoimmune disorder characterized by an increased type 1 interferon gene signature. The engagement of stimulator of interferon genes (STING)…
  • Abstract Number: 2808 • 2019 ACR/ARP Annual Meeting

    Linking Toll-Like Receptor Signaling and Type I Interferons to Inflammation and Fibrosis in a Macrophage/Fibroblast Model of Congenital Heart Block

    Miao Chang1, Robert Clancy 1 and Jill Buyon 1, 1NYU School of Medicine, New York

    Background/Purpose: Since one of the strongest associations with antibodies (abs) to SSA/Ro (Ro60) is the development of congenital heart block (CHB), this model provides an…
  • Abstract Number: 2809 • 2019 ACR/ARP Annual Meeting

    Single-Cell RNA Sequencing of Murine Neutrophils Identifies a Transcriptional Continuum (“Neutrotime”) Across Biological Compartments

    Ricardo Grieshaber-Bouyer1, Giuseppina Stifano 2, Pierre Cunin 3, Anaïs Levescot 4, Nathan Nelson-Maney 4, Rachel Blaustein 5, Paul Monach 6, Peter Nigrovic 7 and ImmGen Consortium 8, 1Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA; Department of Orthopedics, Heidelberg University Hospital, Heidelberg, Germany, Boston, MA, 2Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, Boston, 3Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 4Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, 5Brigham and Women's Hospital, Boston, 6Brigham and Women's Hospital, Boston, MA, 7Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA ; Department of Medicine, Division of Immunology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA., Boston, 8Harvard Medical School, Boston

    Background/Purpose: Neutrophils are key first responders of innate immunity, participating in both defense and inflammatory disease. Phenotypic heterogeneity is recognized but the existence of bone…
  • Abstract Number: 2810 • 2019 ACR/ARP Annual Meeting

    Does Loss-of-function Variants in SAT1 Cause X-linked Pediatric Lupus?

    Ling-Xiao Xu 1, Jian Zhao 2, Qing Sun 2, Lin-Yu Geng 2, Yun Deng 2, Diane Kamen 2, Jim Oates 3, Prithvi Raj 4, Edward Wakeland 4, R.Hal Scofield 5, Joel Guthridge 6, Judith James 6, Deborah McCurdy 7 and Betty Tsao8, 1Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Charelston, SC, 2Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Charleston, SC, 3Division of Rheumatology & Immunology/Medical University of South Carolina, Charleston, SC, 4Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Dallas, 5Arthritis & Clinical Immunology Research Program, Division of Genomics and Data Sciences, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Los Angeles, 6Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 7University of California, MDCC 12-430, 10833 Le Conte Ave, Los Angeles, 90095, CA, USA, Los Angeles, 8Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., Charleston

    Background/Purpose: Mendelian inheritances of highly penetrant single gene variants have been reported as monogenic forms of SLE. To explore novel risk variants, we carried out…
  • Abstract Number: 2811 • 2019 ACR/ARP Annual Meeting

    The IRE1α Pathway Mediates Neutrophil Stress and NETosis in Lupus

    Gautam Sule1, Basel Abuaita 1, Paul Steffes 1, Kristen Gilley 1, Andrew Fernandes 1, Mary O’Riordan 1 and Jason Knight 2, 1University of Michigan, Ann Arbor, MI, 2Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI

    Background/Purpose: Immune complex (IC)-activated neutrophils appear to amplify inflammation in lupus through the release of neutrophil extracellular traps (NETosis).  There is presently no consensus as…
  • Abstract Number: 2812 • 2019 ACR/ARP Annual Meeting

    A New Role for Selectins in Systemic Lupus Erythematosus

    Marc SCHERLINGER1, Vivien Guillotin 2, Pierre Vacher 3, Vanja Sisirak 4, isabelle Douchet 4, Nathalie Merillon 4, Pierre Duffau 5, Estibaliz Lazaro 6, Emmanuel Ribeiro 7, Christophe Richez 8 and Patrick BLANCO 9, 1CHU de Bordeaux, Immunoconcept, Bordeaux, France, 2CHU de Bordeaux, Bordeaux, France, 3INSERM ACTION U1218, Bordeaux, France, 4Immunoconcept, Bordeaux, France, 5Department of Internal Medicine and Clinical Immunology , Hôpital Saint-André, CHU de Bordeaux , Bordeaux , France., Bordeaux, Aquitaine, France, 6FHU ACRONIM, Department of Internal Medecine, Centre Hospitalier Universitaire, Bordeaux, France, Pessac, France, 7CHU de Bordeaux, Bordeaux, 8Pellegrin Hospital, University Hospital of Bordeaux, Bordeaux, France, 9CNRS-UMR 5164 - ImmunoConcEpt, Bordeaux University - Immunology and Immunogenetic Department Bordeaux University Hospital, Bordeaux, Aquitaine, France

    Background/Purpose: In systemic lupus erythematosus (SLE), blood platelets have an activated phenotype, and express high levels of CD40L and P-selectin. Our group demonstrated that SLE…
  • Abstract Number: 2813 • 2019 ACR/ARP Annual Meeting

    Pentameric, but Not Monomeric C-reactive Protein, Limits the SnRNP-immune Complex Triggered Type I Interferon Response: Implications for Lupus Pathogenesis

    Cecilia Svanberg 1, Helena Enocsson 1, Klara Martinsson 1, Lawrence Potempa 2, Ibraheem Rajab 2, Jonas Wetterö 1, Marie Larsson 1 and Christopher Sjöwall3, 1Linköping University, Linköping, Sweden, 2Roosevelt University, Chicago, IL, 3Department of Clinical and Experimental Medicine, Rheumatology/Division of Neuro and Inflammation Sciences, Linköping University, Linköping, Sweden

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune systemic disease affecting multiple organs and which is characterized by autoantibodies directed against nuclear constituents. Common autoantibody…
  • Abstract Number: 2814 • 2019 ACR/ARP Annual Meeting

    Methionine Commits Immunometabolism and Epigenetic Regulation of BACH2 Loci in B Cells, Resulting in Biases Toward Plasmablast Differentiation in the Pathogenesis of SLE

    Mingzeng Zhang1, Shigeru Iwata 1, Maiko Hajime 1, Naoaki Ohkubo 1, Yasuyuki Todoroki 2, Hiroko Miyata 2, Jie Fan 2, Shingo Nakayamada 1, Kaoru Yamagata 1 and Yoshiya Tanaka 3, 1The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan, Kitakyushu, Japan, 2The First Department of Internal Medicine, University of Occupational & Environmental Health Kitakyushu, Japan, Kitakyushu, Japan, 3University of Occupational and Environmental Health Japan, Kitakyushu, Japan

    Background/Purpose: Amino acids play an important role in various metabolic processes. However, the role of amino acid metabolism in the regulation of human B cell…
  • Abstract Number: 2815 • 2019 ACR/ARP Annual Meeting

    Lower IL-4R in IgD+ Naïve B Cells Is a Pre-disposing Factor for Development of T-bet+ DN2 B Cells in Systemic Lupus Erythematosus

    John Mountz1, Min Gao 2, Qi Wu 3, PingAr Yang 2, Alex Essman 4, Oluwagbemiga Ojo 4, Shanrun Liu 2, Jake Chen 2, Iñaki Sanz 5, W. Winn Chatham 2 and Hui-Chen Hsu 2, 1University of Alabama at Birmingham and Birmingham VAMC, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, 3University of Alabama at Birmingham, Birmingham, AL, 4Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, 5Emory University, ATLANTA, GA

    Background/Purpose: Studies to date have primarily focused on stimulators that are overexpressed and activate B cells in SLE subjects.  Factors that can maintain B cells…
  • Abstract Number: 2816 • 2019 ACR/ARP Annual Meeting

    An Expanded Granzyme K+ CD8 T Cell Population Induces Inflammatory Responses in Rheumatoid Arthritis Synovium

    Anna Helena Jonsson1, Fan Zhang 2, Gerald Watts 2, Kevin Wei 1, Deepak Rao 2, Soumya Raychaudhuri 2 and Michael Brenner 3, 1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Brigham and Women’s Hospital:, Boston

    Background/Purpose: CD8 T cells represent nearly half of T cells in inflamed synovium from patients with rheumatoid arthritis (RA). Research to date has focused on…
  • Abstract Number: 2817 • 2019 ACR/ARP Annual Meeting

    Lysosomal Placement of the Energy Sensors AMPK and mTORC1 Controls Tissue Inflammation in Rheumatoid Arthritis

    Zhenke Wen 1, Ke Jin 1, Yinyin Li 1, Bowen Wu 1, Jorg Goronzy 1 and Cornelia Weyand1, 1Stanford University, Stanford, CA

    Background/Purpose: CD4 T cells from patients with rheumatoid arthritis (RA) are metabolically reprogrammed, diverting glucose away from glycolysis towards the production of biosynthetic precursors. Several…
  • Abstract Number: 2818 • 2019 ACR/ARP Annual Meeting

    Differences in the Phenotypic Landscape and Antigen Specificity of CD4+ T Cells Are Present in CCP+ Subjects Before the Onset of Rheumatoid Arthritis

    Virginia Muir 1, Cliff Rims 1, Kevin Deane 2, Jeffrey Carlin 3, Sylvia Posso 1, Sunil Nagpal 4, Navin Rao 4, Frédéric Baribaud 5, George Vratsanos 6, William Robinson 7, Gary Firestein 8, V. Michael Holers 9, Peter Linsley 1, Eddie James1 and Jane Buckner 1, 1Benaroya Research Institute, Seattle, WA, 2University of Colorado Denver, Division of Rheumatology, Aurora, CO, USA, Aurora, CO, 3Virginia Mason Medical Center, Seattle, WA, 4Janssen R&D, Spring House, PA, 5Janssen Research & Development, LLC, Spring House, PA, 6JNJ, Raritan, NJ, 7Stanford University, Palo Alto, CA, 8University of California, San Diego, San Diego, 9University of Colorado Denver, Division of Rheumatology, Aurora, CO, USA, Denver

    Background/Purpose: The “Targeting Immune Responses for Prevention of RA” (TIP-RA) collaboration studies individuals at high risk for developing rheumatoid arthritis (RA) because of serum anti-citrullinated…
  • Abstract Number: 2819 • 2019 ACR/ARP Annual Meeting

    The Transcription Factor MAF Controls the Ability of T Peripheral Helper (Tph) Cells to Help B Cells

    Alexandra Bocharnikov1, Vanessa Wacleche 1, Ye Cao 1 and Deepak Rao 2, 1Brigham and Women's Hospital, Boston, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Pathologic T cell-B cell interactions are hallmark features of many autoimmune diseases. PD-1hi CXCR5- T peripheral helper (Tph) cells are B cell-helper T cells…
  • « Previous Page
  • 1
  • …
  • 1125
  • 1126
  • 1127
  • 1128
  • 1129
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology